Stock MYNZ MAINZ BIOMED N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Mainz Biomed N.V.

Equities

MYNZ

NL0015000LC2

Delayed Nasdaq
Other stock markets
 01:08:11 2024-04-19 pm EDT 		5-day change 1st Jan Change
0.8925 USD -1.27% Intraday chart for Mainz Biomed N.V. -7.99% -23.06%
Apr. 09 Mainz Biomed N.V. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 05 Mainz Biomed N.V. Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cantor Fitzgerald Downgrades Mainz Biomed to Neutral From Overweight
MT
HC Wainwright Adjusts Mainz Biomed's Price Target to $5 From $9, Keeps Buy Rating
MT
HC Wainwright Adjusts Mainz Biomed Price Target to $7 From $10, Maintains Buy Rating
MT
Cantor Fitzgerald Adjusts Price Target on Mainz Biomed to $12 From $15, Keeps Overweight Rating
MT
HC Wainwright Adjusts Price Target on Mainz Biomed to $10 From $25, Reiterates Buy Rating
MT
JonesTrading Initiates Mainz Biomed B.V at Buy With $11 Price Target
MT
Cantor Fitzgerald Starts Mainz Biomed at Overweight With $15 Price Target
MT
HC Wainwright Initiates Mainz Biomed at Buy With $25 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MYNZ Stock
  4. News Mainz Biomed N.V.
  5. Analyst Reco.